文献速递肿瘤 PET/CT核素与放射性配体治疗

局部晚期头颈癌放化疗早期多模态功能影像参数变化预测治疗反应

Changes in multimodality functional imaging parameters early during chemoradiation predict treatment response in patients with locally advanced head and neck cancer.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2017-11-21

35例III-IVb期头颈鳞癌患者前瞻性接受放化疗,于基线、第1周和第2周行18F-FDG-PET/CT及DW、DCE、SW MRI。27例应答者与8例非应答者比较,PET参数第1周可区分两组,MRI参数第2周才可区分,ADC是最强预测因子(∆>17%,AUC 0.937)。

要点

  • PET的TLG40%和SUVmax在第1周可区分应答者与非应答者,第2周差异消失。
  • MRI的ADC、Ktrans和Ve在第2周可区分两组,应答者升高更明显。
  • ADC为最强预测因子(∆>17%,AUC 0.937)。

核心结论

  • FDG-PET、DW和DCE MRI参数的治疗早期变化可预测头颈鳞癌放化疗的最终反应。
  • FDG-PET参数的最佳评估时间为第1周,MRI参数为第2周。
  • 这凸显了扫描时间点对功能与分子影像风险分层干预研究设计的重要性。

研究设计与样本

  • 前瞻性研究,纳入35例III-IVb期(AJCC第7版)头颈鳞癌患者。
  • 于基线、放化疗第1周和第2周行18F-FDG-PET/CT及DW、DCE、SW MRI。
  • 随访期间持续或复发疾病者归为非应答者,余为应答者。
  • 采用Mann-Whitney U检验比较应答者与非应答者第1周和第2周的功能与分子影像参数变化,显著性阈值P<0.05。

主要发现

  • 27例应答者,8例非应答者。
  • 应答者第1周PET肿瘤总病灶糖酵解(TLG40%)下降大于非应答者(P=0.007)。
  • 应答者第1周SUVmax下降大于非应答者(P=0.034),第2周两组差异消失。
  • 第2周应答者原发肿瘤ADC升高幅度大于非应答者(P<0.001)。
  • 第2周应答者Ktrans(P=0.012)和Ve(P=0.047)升高幅度大于非应答者。

关键数值与推荐

  • PET参数第1周:TLG40%变化P=0.007,SUVmax变化P=0.034。
  • MRI参数第2周:ADC变化P<0.001,Ktrans变化P=0.012,Ve变化P=0.047。
  • ADC预测效能:∆>17%,AUC 0.937。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the optimal timing and predictive value of early intra-treatment changes in multimodality functional and molecular imaging (FMI) parameters as biomarkers for clinical remission in patients receiving chemoradiation for head and neck squamous cell carcinoma (HNSCC). METHODS: Thirty-five patients with stage III-IVb (AJCC 7th edition) HNSCC prospectively underwent 18F-FDG-PET/CT, and diffusion-weighted (DW), dynamic contrast-enhanced (DCE) and susceptibility-weighted MRI at baseline, week 1 and week 2 of chemoradiation. Patients with evidence of persistent or recurrent disease during follow-up were classed as non-responders. Changes in FMI parameters at week 1 and week 2 were compared between responders and non-responders with the Mann-Whitney U test. The significance threshold was set at a p value of <0.05. RESULTS: There were 27 responders and 8 non-responders. Responders showed a greater reduction in PET-derived tumor total lesion glycolysis (TLG40%; p = 0.007) and maximum standardized uptake value (SUVmax; p = 0.034) after week 1 than non-responders but these differences were absent by week 2. In contrast, it was not until week 2 that MRI-derived parameters were able to discriminate between the two groups: larger fractional increases in primary tumor apparent diffusion coefficient (ADC; p < 0.001), volume transfer constant (Ktrans; p = 0.012) and interstitial space volume fraction (Ve; p = 0.047) were observed in responders versus non-responders. ADC was the most powerful predictor (∆ >17%, AUC 0.937). CONCLUSION: Early intra-treatment changes in FDG-PET, DW and DCE MRI-derived parameters are predictive of ultimate response to chemoradiation in HNSCC. However, the optimal timing for assessment with FDG-PET parameters (week 1) differed from MRI parameters (week 2). This highlighted the importance of scanning time points for the design of FMI risk-stratified interventional studies.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Wong KH, Panek R, Dunlop A, et al. Changes in multimodality functional imaging parameters early during chemoradiation predict treatment response in patients with locally advanced head and neck cancer. Eur J Nucl Med Mol Imaging. 2017. PMID: 29164301. doi:10.1007/s00259-017-3890-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。